Jane Street’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Sell
60,815
-218,792
-78% -$6.5M ﹤0.01% 6143
2025
Q4
$8.7M Buy
279,607
+244,193
+690% +$6.7M 0.01% 2494
2025
Q3
$764K Buy
35,414
+24,677
+230% +$445K ﹤0.01% 6897
2025
Q2
$150K Sell
10,737
-64,449
-86% -$875K ﹤0.01% 8747
2025
Q1
$1.01M Buy
75,186
+27,164
+57% +$463K ﹤0.01% 5548
2024
Q4
$921K Sell
48,022
-303,131
-86% -$6.59M ﹤0.01% 5546
2024
Q3
$7.99M Buy
351,153
+238,078
+211% +$3.89M 0.01% 2170
2024
Q2
$1.47M Buy
113,075
+63,393
+128% +$878K ﹤0.01% 5047
2024
Q1
$870K Sell
49,682
-18,286
-27% -$354K ﹤0.01% 5662
2023
Q4
$1.48M Buy
67,968
+8,332
+14% +$132K ﹤0.01% 4843
2023
Q3
$915K Sell
59,636
-140,113
-70% -$2.67M ﹤0.01% 5308
2023
Q2
$4.75M Buy
199,749
+156,704
+364% +$4.02M 0.01% 2812
2023
Q1
$1.1M Buy
+43,045
New +$1.38M ﹤0.01% 4827
2022
Q4
Hold
0
10296
2022
Q3
Hold
0
10627
2022
Q2
Sell
-61,518
Closed -$1.14M 11078
2022
Q1
$1.14M Buy
+61,518
New +$1.18M ﹤0.01% 5867
2019
Q3
Sell
-5,174
Closed -$159K 5853
2019
Q2
$159K Buy
+5,174
New +$208K ﹤0.01% 4752
2018
Q2
Sell
-672
Closed -$71K 5763
2018
Q1
$71K Buy
+672
New +$73K ﹤0.01% 4652

Other funds holding VRDN